Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 112801-112850 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02840747
Tissue Repository: CTCL Collection Protocol
N/A
Recruiting
400 participants
Started: Jul 31, 2016 · Completed: Oct 31, 2025
3 conditions
1 sponsor
1 location
NCT02743910
Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer
N/A
Active, not recruiting
229 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT02688491
A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
NA
Not yet recruiting
300 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
2 conditions
4 sponsors
0 locations
NCT02728076
MRI-Based Preoperative Accelerated Partial Breast Irradiation
NA
Active, not recruiting
39 participants
Started: Jul 29, 2016 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03299569
Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
N/A
Recruiting
800 participants
Started: Jul 29, 2016 · Completed: Dec 31, 2028
2 conditions
8 sponsors
1 location
NCT04925531
Antibiotic Use in Facial Fracture Post Injury
N/A
Recruiting
1,000 participants
Started: Jul 29, 2016 · Completed: Jul 23, 2024
1 condition
1 sponsor
1 location
NCT04084145
National Unified Renal Translation Research Enterprise - Chronic Kidney Disease
N/A
Active, not recruiting
3,004 participants
Started: Jul 27, 2016 · Completed: Dec 31, 2032
1 condition
11 sponsors
2 locations
NCT02797561
Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
N/A
Recruiting
1,000 participants
Started: Jul 25, 2016 · Completed: Dec 31, 2027
1 condition
2 sponsors
14 locations
NCT02843425
The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial
NA
Active, not recruiting
71 participants
Started: Jul 25, 2016 · Completed: Apr 1, 2027
1 condition
1 sponsor
1 location
NCT02842619
Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone Regeneration
PHASE1/PHASE2
Active, not recruiting
27 participants
Started: Jul 23, 2016 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT02754544
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
NA
Recruiting
75 participants
Started: Jul 22, 2016 · Completed: Jan 1, 2028
3 conditions
3 sponsors
1 location
NCT02595944
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
PHASE3
Active, not recruiting
903 participants
Started: Jul 22, 2016 · Completed: Dec 31, 2026
3 conditions
1 sponsor
888 locations
NCT02595931
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
PHASE1
Active, not recruiting
66 participants
Started: Jul 22, 2016 · Completed: Mar 6, 2026
18 conditions
1 sponsor
23 locations
NCT02707029
Clinical and Scientific Assessment of Pain and Painful Disorders
N/A
Recruiting
10,000 participants
Started: Jul 22, 2016 · Completed: Feb 9, 2026
2 conditions
1 sponsor
1 location
NCT03519074
Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
PHASE2
Active, not recruiting
48 participants
Started: Jul 22, 2016 · Completed: Dec 20, 2025
2 conditions
1 sponsor
2 locations
NCT03273049
Mapping Disease Pathways for Biliary Atresia
N/A
Recruiting
1,100 participants
Started: Jul 21, 2016 · Completed: Jul 21, 2035
1 condition
3 sponsors
1 location
NCT02941458
Thoracic Tumours Register
N/A
Recruiting
10,000 participants
Started: Jul 21, 2016 · Completed: Dec 30, 2030
1 condition
1 sponsor
79 locations
NCT03068910
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
EARLY_PHASE1
Recruiting
32 participants
Started: Jul 21, 2016 · Completed: Dec 1, 2025
3 conditions
2 sponsors
1 location
NCT03322891
Improving Health Literacy in African-American Prostate Cancer Patients
NA
Recruiting
150 participants
Started: Jul 21, 2016 · Completed: Mar 31, 2027
1 condition
2 sponsors
4 locations
NCT03877276
Dietary Oxalate and Immune Cell Function
NA
Active, not recruiting
82 participants
Started: Jul 21, 2016 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT03011684
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
PHASE3
Recruiting
309 participants
Started: Jul 21, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04977791
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
N/A
Recruiting
250 participants
Started: Jul 21, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02719106
IRIS Ultimaster Cohort in the IRIS-DES Registry
N/A
Active, not recruiting
1,000 participants
Started: Jul 20, 2016 · Completed: Jul 24, 2024
1 condition
2 sponsors
15 locations
NCT02603887
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Jul 20, 2016 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT02698254
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy
NA
Active, not recruiting
40 participants
Started: Jul 20, 2016 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT04537390
Anti-mullerian Hormone Levels in Healthy Females
NA
Recruiting
100 participants
Started: Jul 19, 2016 · Completed: Dec 1, 2030
1 condition
2 sponsors
1 location
NCT02489006
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
PHASE2
Active, not recruiting
71 participants
Started: Jul 19, 2016 · Completed: Dec 31, 2025
4 conditions
1 sponsor
9 locations
NCT02642042
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
60 participants
Started: Jul 18, 2016 · Completed: Mar 19, 2026
3 conditions
1 sponsor
601 locations
NCT04838899
Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
NA
Recruiting
30 participants
Started: Jul 16, 2016 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03967600
Clinical and Biological Characteristics of Hidradenitis Suppurativa
N/A
Recruiting
1,000 participants
Started: Jul 15, 2016 · Completed: Jul 15, 2026
1 condition
1 sponsor
1 location
NCT02743741
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
NA
Active, not recruiting
195 participants
Started: Jul 15, 2016 · Completed: Jun 30, 2026
1 condition
4 sponsors
4 locations
NCT02827877
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer
PHASE2
Active, not recruiting
18 participants
Started: Jul 15, 2016 · Completed: Oct 16, 2025
4 conditions
2 sponsors
1 location
NCT02719613
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
PHASE2
Active, not recruiting
67 participants
Started: Jul 15, 2016 · Completed: Nov 13, 2025
1 condition
2 sponsors
41 locations
NCT02790515
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
PHASE2
Active, not recruiting
170 participants
Started: Jul 14, 2016 · Completed: Jul 1, 2026
7 conditions
1 sponsor
1 location
NCT02632305
A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
PHASE2
Active, not recruiting
45 participants
Started: Jul 13, 2016 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT02978911
Cranial Nerves Tractography
NA
Recruiting
120 participants
Started: Jul 12, 2016 · Completed: Jul 12, 2026
1 condition
1 sponsor
1 location
NCT02769975
Evaluation of Children With Endocrine and Metabolic-Related Conditions
N/A
Recruiting
15,000 participants
Started: Jul 12, 2016 · Completed: Dec 31, 2030
5 conditions
1 sponsor
1 location
NCT02917798
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
N/A
Active, not recruiting
1,047 participants
Started: Jul 12, 2016 · Completed: Sep 30, 2026
3 conditions
2 sponsors
5 locations
NCT02761070
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
PHASE3
Active, not recruiting
146 participants
Started: Jul 11, 2016 · Completed: Nov 10, 2025
3 conditions
2 sponsors
37 locations
NCT02655016
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
PHASE3
Active, not recruiting
733 participants
Started: Jul 11, 2016 · Completed: Jan 30, 2026
1 condition
4 sponsors
200 locations
NCT02741440
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
N/A
Recruiting
25 participants
Started: Jul 11, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02830308
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
N/A
Recruiting
1,250 participants
Started: Jul 9, 2016 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT02817633
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
PHASE1
Recruiting
447 participants
Started: Jul 8, 2016 · Completed: Apr 27, 2027
1 condition
1 sponsor
96 locations
NCT02756897
Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia
PHASE2
Active, not recruiting
234 participants
Started: Jul 7, 2016 · Completed: Jul 1, 2027
6 conditions
1 sponsor
1 location
NCT05709730
Follow-up of Cell Changes in the Cervix
N/A
Active, not recruiting
885 participants
Started: Jul 7, 2016 · Completed: Dec 1, 2029
1 condition
1 sponsor
1 location
NCT02769520
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
PHASE2
Active, not recruiting
27 participants
Started: Jul 6, 2016 · Completed: Apr 30, 2026
1 condition
2 sponsors
3 locations
NCT02756962
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
PHASE2
Active, not recruiting
107 participants
Started: Jul 6, 2016 · Completed: Jul 31, 2029
1 condition
3 sponsors
3 locations
NCT02726997
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Jul 6, 2016 · Completed: Dec 31, 2025
15 conditions
2 sponsors
1 location
NCT02744677
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
NA
Recruiting
108 participants
Started: Jul 5, 2016 · Completed: Jun 30, 2031
4 conditions
1 sponsor
25 locations
NCT03729687
Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer
PHASE2
Active, not recruiting
280 participants
Started: Jul 4, 2016 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
2254
2255
2256
2257
2258
2259
2260
More pages
2369
Next